Kohsuke Mamiya

1.1k total citations
16 papers, 837 citations indexed

About

Kohsuke Mamiya is a scholar working on Pediatrics, Perinatology and Child Health, Pharmacology and Psychiatry and Mental health. According to data from OpenAlex, Kohsuke Mamiya has authored 16 papers receiving a total of 837 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pediatrics, Perinatology and Child Health, 11 papers in Pharmacology and 8 papers in Psychiatry and Mental health. Recurrent topics in Kohsuke Mamiya's work include Pharmacogenetics and Drug Metabolism (11 papers), Pharmacological Effects and Toxicity Studies (10 papers) and Epilepsy research and treatment (7 papers). Kohsuke Mamiya is often cited by papers focused on Pharmacogenetics and Drug Metabolism (11 papers), Pharmacological Effects and Toxicity Studies (10 papers) and Epilepsy research and treatment (7 papers). Kohsuke Mamiya collaborates with scholars based in Japan, United States and Belgium. Kohsuke Mamiya's co-authors include Ichiro Ieiri, Shun Higuchi, Hideaki Ninomiya, Eiji Yukawa, Nobutada Tashiro, Miyuki Kimura, Akinori Urae, Kenji Otsubo, Jun Imai and S. Matsuo and has published in prestigious journals such as Epilepsia, British Journal of Clinical Pharmacology and European Journal of Clinical Pharmacology.

In The Last Decade

Kohsuke Mamiya

16 papers receiving 811 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kohsuke Mamiya Japan 14 543 378 347 197 131 16 837
Harri Luurila Finland 12 399 0.7× 277 0.7× 236 0.7× 131 0.7× 140 1.1× 20 897
Erik Skjelbo Denmark 12 748 1.4× 276 0.7× 177 0.5× 239 1.2× 322 2.5× 17 1.1k
K. Br�sen Denmark 11 478 0.9× 220 0.6× 157 0.5× 152 0.8× 242 1.8× 13 915
Marja-Liisa Dahl Sweden 13 740 1.4× 307 0.8× 129 0.4× 147 0.7× 231 1.8× 15 970
Leif Bertilsson Sweden 10 607 1.1× 267 0.7× 140 0.4× 85 0.4× 145 1.1× 11 933
J BROCKMOLLER Germany 8 553 1.0× 242 0.6× 173 0.5× 71 0.4× 149 1.1× 11 790
Sebastian Raimundo Germany 8 985 1.8× 431 1.1× 179 0.5× 104 0.5× 208 1.6× 9 1.2k
Michel Eichelbaum Germany 11 349 0.6× 560 1.5× 388 1.1× 97 0.5× 87 0.7× 14 931
Houda Hachad United States 16 672 1.2× 200 0.5× 382 1.1× 179 0.9× 99 0.8× 25 1.1k
Johanna Sistonen Finland 18 728 1.3× 345 0.9× 300 0.9× 79 0.4× 152 1.2× 34 1.3k

Countries citing papers authored by Kohsuke Mamiya

Since Specialization
Citations

This map shows the geographic impact of Kohsuke Mamiya's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kohsuke Mamiya with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kohsuke Mamiya more than expected).

Fields of papers citing papers by Kohsuke Mamiya

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kohsuke Mamiya. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kohsuke Mamiya. The network helps show where Kohsuke Mamiya may publish in the future.

Co-authorship network of co-authors of Kohsuke Mamiya

This figure shows the co-authorship network connecting the top 25 collaborators of Kohsuke Mamiya. A scholar is included among the top collaborators of Kohsuke Mamiya based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kohsuke Mamiya. Kohsuke Mamiya is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Yukawa, Eiji & Kohsuke Mamiya. (2006). Effect of CYP2C19 genetic polymorphism on pharmacokinetics of phenytoin and phenobarbital in Japanese epileptic patients using Non-linear Mixed Effects Model approach. Journal of Clinical Pharmacy and Therapeutics. 31(3). 275–282. 36 indexed citations
2.
Mamiya, Kohsuke, et al.. (2005). Lithium concentration correlates with QTc in patients with psychosis. Journal of Electrocardiology. 38(2). 148–151. 28 indexed citations
3.
Ieiri, Ichiro, Sérgio Yamada, Toshihiro Morita, et al.. (2003). A CYP2D6 Phenotype-Genotype Mismatch in Japanese Psychiatric Patients. Pharmacopsychiatry. 36(5). 192–196. 13 indexed citations
5.
Mamiya, Kohsuke, et al.. (2001). Phenytoin Intoxication Induced by Fluvoxamine. Therapeutic Drug Monitoring. 23(1). 75–77. 23 indexed citations
6.
Ieiri, Ichiro, Toshihiro Morita, Miyuki Kimura, et al.. (2001). P-Hydroxylation of Phenobarbital: Relationship to (s)-Mephenytoin Hydroxylation (CYP2C19) Polymorphism. Therapeutic Drug Monitoring. 23(2). 115–118. 22 indexed citations
7.
Mamiya, Kohsuke, Eiji Yukawa, Ichiro Ieiri, et al.. (2000). CYP2C19 polymorphism effect on phenobarbitone. European Journal of Clinical Pharmacology. 55(11-12). 821–825. 57 indexed citations
8.
Imai, Jun, Ichiro Ieiri, Kohsuke Mamiya, et al.. (2000). Polymorphism of the cytochrome P450 (CYP) 2C9 gene in Japanese epileptic patients: genetic analysis of the CYP2C9 locus. Pharmacogenetics. 10(1). 85–89. 114 indexed citations
9.
Mamiya, Kohsuke, Eiji Yukawa, Ichiro Ieiri, et al.. (2000). Pharmacokineties in Japanese patients with epilepsy: analysis by population pharmacokinetics. 1 indexed citations
10.
Ieiri, Ichiro, Hitoshi Tainaka, Toshihiro Morita, et al.. (2000). Catalytic Activity of Three Variants (Ile, Leu, and Thr) at Amino Acid Residue 359 in Human CYP2C9 Gene and Simultaneous Detection Using Single-Strand Conformation Polymorphism Analysis. Therapeutic Drug Monitoring. 22(3). 237–244. 63 indexed citations
11.
Ninomiya, Hideaki, Kohsuke Mamiya, S. Matsuo, et al.. (2000). Genetic Polymorphism of the CYP2C Subfamily and Excessive Serum Phenytoin Concentration With Central Nervous System Intoxication. Therapeutic Drug Monitoring. 22(2). 230–232. 95 indexed citations
12.
Kimura, Miyuki, et al.. (1999). Reliability of the omeprazole hydroxylation index for CYP2C19 phenotyping: possible effect of age, liver disease and length of therapy. British Journal of Clinical Pharmacology. 47(1). 115–119. 32 indexed citations
14.
Kimura, Miyuki, Ichiro Ieiri, Kohsuke Mamiya, Akinori Urae, & Shun Higuchi. (1998). Genetic Polymorphism of Cytochrome P450s, CYP2C19, and CYP2C9 in a Japanese Population. Therapeutic Drug Monitoring. 20(3). 243–247. 168 indexed citations
15.
Mamiya, Kohsuke, Ichiro Ieiri, Jun Imai, et al.. (1998). Hydroxylation of Phenytoin (PHT) and the Cytochrome P450 (CYP) 2C Subfamily. Epilepsia. 39(S5). 82–83. 1 indexed citations
16.
Ieiri, Ichiro, Kohsuke Mamiya, Akinori Urae, et al.. (1997). Stereoselective 4′‐hydroxylation of phenytoin: relationship to (S)‐mephenytoin polymorphism in Japanese. British Journal of Clinical Pharmacology. 43(4). 441–445. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026